SB616 Relative to reporting requirements under the right to try act.
Relative to reporting requirements under the right to try act.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
Reporting requirements have minimal direct cost impact.
Your Community
Better data on experimental treatments helps inform future patients and their doctors making life-or-death decisions.
Your Freedom
Supports informed decision-making for terminally ill patients accessing experimental treatments.
Status
Pending Motion OT3rdg; 03/12/2026; Senate Journal 6
Sponsor
Suzanne Prentiss (D)
The Short Version
Updates reporting requirements under NH's Right to Try Act, which allows terminally ill patients to access experimental treatments. Improves data collection on outcomes of these treatments.
Who's Behind This Bill?
Who Benefits
- ▲ Terminally ill patients considering experimental treatments
- ▲ Healthcare providers
- ▲ Medical researchers
Who Pays the Price
- ▼ Providers bearing minor reporting burden
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.